What is the revenue of Fosun Pharma?
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. generates annual revenues exceeding ₹525 billion to ₹570 billion (translating to tens of billions of Chinese yuan equivalents), highlighting its major role as a leading healthcare and pharmaceutical enterprise. The corporation drives substantial top-line growth through comprehensive pharmaceutical manufacturing, medical device technologies, healthcare services, and global distribution networks.
Related FAQs
Manufacturer codes, ticker identifiers, and regulatory registration prefixes associated with Shanghai Fosun Pharmaceutical Group vary depending on the specific stock exchange listing, customs database, or pharmaceutical compliance framework.
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is a leading healthcare and biopharmaceutical enterprise dedicated to medical innovation, research, development, and commercialization of advanced healthcare products.
Fosun International historically ranks within the elite upper tier of major global enterprises on the annual Forbes Global 2000 list, securing positions typically around the 371st spot or higher depending on annual market fluctuations.
Fosun International is indeed a publicly listed corporate entity, maintaining its primary equity listing on the Hong Kong Stock Exchange.
Fosun is not in imminent financial default, though it has navigated a challenging period of liquidity pressures, real estate impairments, and credit scrutiny.
Fosun International was founded in 1992 in Shanghai, China, by Guo Guangchang, Liang Xinjun, and other graduates of Fudan University, initially starting as a market research and consulting enterprise under the name Guangxin Technology.
Foxconn (Hon Hai Precision Industry Co., Ltd.) commands a massive corporate market capitalization of approximately $111 billion USD (or roughly ₹10.563 trillion).
Fosun International operates as a massive multinational investment holding and industrial conglomerate with a primary focus on technology-driven consumer businesses.
Yes, Franklin Electric pumps are widely regarded as exceptionally high-quality, durable, and reliable fluid-handling systems.
Fosun International, a massive Chinese multinational conglomerate, holds majority ownership of the historic English professional football club Wolverhampton Wanderers, commonly known as Wolves.
Fosun International Limited (HKG: 0656) shares trade at a live market price of approximately HK$4.74 per share.
Fosun International Limited is a major publicly listed enterprise, with its common shares traded on the main board of the Stock Exchange of Hong Kong under the stock code 0656.
Fosun International is not owned or controlled by the Chinese government, operating instead as a prominent privately founded multinational conglomerate.
Shanghai Fosun Pharmaceutical (Group) Co., Ltd., a leading Chinese healthcare and pharmaceutical enterprise, has its primary corporate headquarters located in Shanghai, China.